Citations (18)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Aleksander Lenert & Petar Lenert. (2015) Current and emerging treatment options for ANCA-associated vasculitis: potential role of belimumab and other BAFF/APRIL targeting agents. Drug Design, Development and Therapy 9, pages 333-347.
Read now
Read now
Articles from other publishers (17)
Aya H. Eldesouky, Mariam R. Fadel, Somaya A. Husein & Dina O. Abdulazim. (2023) Pattern of non-infectious uveitis and visual outcome in a tertiary care university-based hospital: A multidisciplinary approach. The Egyptian Rheumatologist 45:2, pages 165-169.
Crossref
Crossref
Saket Jha, Jagdeep Singh, Ranjana W. Minz, Aadhar Dhooria, GSRSNK Naidu, Rajiv Ranjan Kumar, Manish Rathi, Sanjay Jain, Shashi Anand & Aman Sharma. (2021) Increased gene expression of B cell‐activating factor of tumor necrosis factor family, in remitting antineutrophil cytoplasmic antibody‐associated vasculitis patients. International Journal of Rheumatic Diseases 25:2, pages 218-227.
Crossref
Crossref
Maged Mohamed Refaat, Azza Mohamed Ahmed Said, Ahmed Abdelmonsef Ebeid, Ahmed Yehia Elmazly & Dina Sayed Sheha. (2021) Ocular manifestations and complications in a cohort of Behçet’s disease patients in a tertiary hospital. The Egyptian Rheumatologist 43:1, pages 81-84.
Crossref
Crossref
Elham Rajaei, Mohammad T. Jalali, Seyed M. Sadegh Pezeshki, Hadi Rezaeeyan, Mahmood Maniati, Milad Elyasi & Zeinab D. Zayeri. (2020) Dose HLA-B5, 7, 8, 27, and 51 Antigens Associated to Behcet's disease? A Study in Southwestern Iran. Current Rheumatology Reviews 16:2, pages 120-124.
Crossref
Crossref
Nermeen A. Fouad, Tarek I. Ahmed, Olfat G. Shaker & Omayma O. Abdelaleem. (2019) Relation of ischemia-modified albumin to disease manifestations and activity in Egyptian patients with Behçet’s disease. Egyptian Rheumatology and Rehabilitation 46:2, pages 108-112.
Crossref
Crossref
Yasser Emad, Safaa Sayed, Ghada S. El-Azkalany, Hussein S. El-Fishawy, Eiman Abd El Latif & Amal H. Eissa. (2018) Relation of anti-annexin V antibodies to disease manifestations and activity in Behҫet’s disease patients. The Egyptian Rheumatologist 40:1, pages 51-54.
Crossref
Crossref
Jurgen Sota, Donato Rigante, Giuseppe Lopalco, Bruno Frediani, Rossella Franceschini, Mauro Galeazzi, Florenzo Iannone, Gian Marco Tosi, Claudia Fabiani & Luca Cantarini. (2017) Biological therapies for the treatment of Behçet’s disease-related uveitis beyond TNF-alpha blockade: a narrative review. Rheumatology International 38:1, pages 25-35.
Crossref
Crossref
Dina M. Rasheed Bahgat, Salma Sa?d & Rasha E. Gheith. (2017) Non-significant influence of macrophage migration inhibitory factor (MIF) promoter gene polymorphisms on the risk or activity of Egyptian Beh?et?s disease patients: Potential role of MIF+254T/C in posterior uveitis. The Egyptian Rheumatologist 39:2, pages 115-120.
Crossref
Crossref
Tamer A Gheita, Heba A Gheita & Sanaa A Kenawy. (2016) The potential of genetically guided treatment in Behçet's disease. Pharmacogenomics 17:10, pages 1165-1174.
Crossref
Crossref
Waleed A. Hassan & Hany H. Ebaid. (2016) Assessment of left ventricular function and aortic elastic properties in patients with Beh?et?s disease using conventional and tissue Doppler echocardiography. The Egyptian Rheumatologist 38:1, pages 47-52.
Crossref
Crossref
Saeedeh Shenavandeh, Maryam Barkhordar, Eskandar Kamali Sarvestani, Elham Aflaki, Zahra Habib Agahi & MohammadAli Nazarinia. (2016) Determination of serum visfatin levels in patients with Beh?et?s disease: A case?control study. The Egyptian Rheumatologist 38:1, pages 41-45.
Crossref
Crossref
Amany R. El-Najjar, Amany M. Abou El-Soud, Hanan A. Amar & Magda Al Sayed Diab. (2015) Clinical characteristics and disease activity of Behçet’s disease patients in Zagazig, Egypt. The Egyptian Rheumatologist 37:4, pages 191-196.
Crossref
Crossref
Lei Han, Wei Zhang, Fulin Song, Yang Guo, Kejian Guo & Wenping Zhou. (2014) Soluble a‑proliferation‑inducing ligand (sAPRIL), a novel serum biomarker predicting the recurrence and metastasis of pancreatic adenocarcinoma after surgery. Molecular Medicine Reports.
Crossref
Crossref
Manal El Menyawi, Mary Fawzy, Zeinab Al-Nahas, Amr Edris, Hanan Hussein, Olfat Shaker & Hussein Elwan. (2014) Serum tumor necrosis factor alpha (TNF-?) level in patients with Beh?et?s disease: Relation to clinical manifestations and disease activity. The Egyptian Rheumatologist 36:3, pages 139-143.
Crossref
Crossref
Amina A. Mahdy, Hala A. Raafat, Hussein S. El-Fishawy & Tamer A. Gheita. (2014) Therapeutic potential of hydroxychloroquine on serum B-cell activating factor belonging to the tumor necrosis factor family (BAFF) in rheumatoid arthritis patients. Bulletin of Faculty of Pharmacy, Cairo University 52:1, pages 37-43.
Crossref
Crossref
Gulen Hatemi, Peter A. Merkel, Vedat Hamuryudan, Maarten Boers, Haner Direskeneli, Sibel Z. Aydin & Hasan Yazici. (2014) Outcome Measures Used in Clinical Trials for Behçet Syndrome: A Systematic Review. The Journal of Rheumatology 41:3, pages 599-612.
Crossref
Crossref
Ahmed Allam, Hatem Ammar & Abdullah Radwan. (2014) Serum homocysteine level and eye involvement in Egyptian patients with Behçet’s disease. The Egyptian Rheumatologist 36:1, pages 29-34.
Crossref
Crossref